Literature DB >> 16487251

Differentiation and immune function of human dendritic cells following infection by respiratory syncytial virus.

A Jones1, I Morton, L Hobson, G S Evans, M L Everard.   

Abstract

RSV causes annual epidemics of bronchiolitis in winter months resulting in the hospitalization of many infants and the elderly. Dendritic cells (DCs) play a pivotal role in coordinating immune responses to infection and some viruses skew, or subvert, the immune functions of DCs. RSV infection of DCs could alter their function and this could explain why protection after natural RSV infection is incomplete and of short duration. In this study, this interaction between DCs and RSV was investigated using a human primary culture model. DCs were generated from purified healthy adult volunteer peripheral blood monocytes. Effects of RSV upon DC phenotype with RSV primed DCs was measured using flow cytometry. Changes to viability and proliferation of cocultured DCs and T-cells were determined using microscopy with fluorescent dyes (Hoechst 33342 and propidium iodide). DC maturation was not prevented by the RSV challenge. RSV infected a fraction of DCs (10-30%) but the virus replicated slowly in these cells with only small reduction to cell viability. DCs challenged with RSV stimulated T-cell proliferation less well than lipopolysaccharide. This is the first study to demonstrate RSV infection of human monocyte derived DCs and suggests that the virus does not significantly interfere with the function of these cells and potentially may promote cellular rather than humoral responses.

Entities:  

Mesh:

Year:  2006        PMID: 16487251      PMCID: PMC1809602          DOI: 10.1111/j.1365-2249.2005.03004.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  34 in total

1.  Infection of dendritic cells by murine cytomegalovirus induces functional paralysis.

Authors:  D M Andrews; C E Andoniou; F Granucci; P Ricciardi-Castagnoli; M A Degli-Esposti
Journal:  Nat Immunol       Date:  2001-11       Impact factor: 25.606

2.  Vaccination of pediatric solid tumor patients with tumor lysate-pulsed dendritic cells can expand specific T cells and mediate tumor regression.

Authors:  J D Geiger; R J Hutchinson; L F Hohenkirk; E A McKenna; G A Yanik; J E Levine; A E Chang; T M Braun; J J Mulé
Journal:  Cancer Res       Date:  2001-12-01       Impact factor: 12.701

3.  Detection of respiratory syncytial virus nucleic acid in archival postmortem tissue from infants.

Authors:  H A Cubie; L A Duncan; L A Marshall; N M Smith
Journal:  Pediatr Pathol Lab Med       Date:  1997 Nov-Dec

4.  Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells.

Authors:  Magdalena Moutaftsi; Anja M Mehl; Leszek K Borysiewicz; Zsuzsanna Tabi
Journal:  Blood       Date:  2002-04-15       Impact factor: 22.113

5.  Cytokine responses of bovine dendritic cells and T cells following exposure to live or inactivated bovine respiratory syncytial virus.

Authors:  Dirk Werling; Robert A Collins; Geraldine Taylor; Chris J Howard
Journal:  J Leukoc Biol       Date:  2002-08       Impact factor: 4.962

6.  Human cytomegalovirus induces a direct inhibitory effect on antigen presentation by monocyte-derived immature dendritic cells.

Authors:  Ulrich Grigoleit; Susanne Riegler; Hermann Einsele; Kerstin Laib Sampaio; Gerhard Jahn; Holger Hebart; Peter Brossart; Friderike Frank; Christian Sinzger
Journal:  Br J Haematol       Date:  2002-10       Impact factor: 6.998

7.  Sustained increases in numbers of pulmonary dendritic cells after respiratory syncytial virus infection.

Authors:  Marc Beyer; Holger Bartz; Katharina Hörner; Sandra Doths; Cordula Koerner-Rettberg; Jürgen Schwarze
Journal:  J Allergy Clin Immunol       Date:  2004-01       Impact factor: 10.793

8.  Respiratory syncytial virus induces prostaglandin E2, IL-10 and IL-11 generation in antigen presenting cells.

Authors:  H Bartz; F Büning-Pfaue; O Türkel; U Schauer
Journal:  Clin Exp Immunol       Date:  2002-09       Impact factor: 4.330

9.  Replication and clearance of respiratory syncytial virus: apoptosis is an important pathway of virus clearance after experimental infection with bovine respiratory syncytial virus.

Authors:  Birgitte Viuff; Kirsten Tjørnehøj; Lars E Larsen; Christine M Røntved; Ase Uttenthal; Leif Rønsholt; Soren Alexandersen
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

Review 10.  Interactions of viruses with dendritic cells: a double-edged sword.

Authors:  N Bhardwaj
Journal:  J Exp Med       Date:  1997-09-15       Impact factor: 14.307

View more
  25 in total

Review 1.  Respiratory dendritic cells: mediators of tolerance and immunity.

Authors:  Ryan A Langlois; Kevin L Legge
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

2.  Central role of dendritic cells in shaping the adaptive immune response during respiratory syncytial virus infection.

Authors:  Daniel S McDermott; Kayla A Weiss; Cory J Knudson; Steven M Varga
Journal:  Future Virol       Date:  2011-08       Impact factor: 1.831

Review 3.  The role of the respiratory syncytial virus in airway syndromes in childhood.

Authors:  Mark L Everard
Journal:  Curr Allergy Asthma Rep       Date:  2006-03       Impact factor: 4.806

4.  Effects of human respiratory syncytial virus, metapneumovirus, parainfluenza virus 3 and influenza virus on CD4+ T cell activation by dendritic cells.

Authors:  Cyril Le Nouën; Philippa Hillyer; Shirin Munir; Christine C Winter; Thomas McCarty; Alexander Bukreyev; Peter L Collins; Ronald L Rabin; Ursula J Buchholz
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

5.  Primary human mDC1, mDC2, and pDC dendritic cells are differentially infected and activated by respiratory syncytial virus.

Authors:  Teresa R Johnson; Christina N Johnson; Kizzmekia S Corbett; Gretchen C Edwards; Barney S Graham
Journal:  PLoS One       Date:  2011-01-28       Impact factor: 3.240

6.  Differential response of human naive and memory/effector T cells to dendritic cells infected by respiratory syncytial virus.

Authors:  T Rothoeft; K Fischer; S Zawatzki; V Schulz; U Schauer; C Körner Rettberg
Journal:  Clin Exp Immunol       Date:  2007-09-24       Impact factor: 4.330

7.  Persistent of respiratory syncytial virus in human dendritic cells and influence of nitric oxide.

Authors:  L Hobson; M L Everard
Journal:  Clin Exp Immunol       Date:  2007-12-06       Impact factor: 4.330

8.  Differential recruitment of dendritic cells and monocytes to respiratory mucosal sites in children with influenza virus or respiratory syncytial virus infection.

Authors:  Michelle A Gill; Kristin Long; Theresa Kwon; Luz Muniz; Asuncion Mejias; John Connolly; Lonnie Roy; Jacques Banchereau; Octavio Ramilo
Journal:  J Infect Dis       Date:  2008-12-01       Impact factor: 5.226

9.  Infection and maturation of monocyte-derived human dendritic cells by human respiratory syncytial virus, human metapneumovirus, and human parainfluenza virus type 3.

Authors:  Cyril Le Nouën; Shirin Munir; Stéphanie Losq; Christine C Winter; Thomas McCarty; David A Stephany; Kevin L Holmes; Alexander Bukreyev; Ronald L Rabin; Peter L Collins; Ursula J Buchholz
Journal:  Virology       Date:  2009-01-06       Impact factor: 3.616

10.  Priming of the Respiratory Tract with Immunobiotic Lactobacillus plantarum Limits Infection of Alveolar Macrophages with Recombinant Pneumonia Virus of Mice (rK2-PVM).

Authors:  Kimberly D Dyer; Rebecca A Drummond; Tyler A Rice; Caroline M Percopo; Todd A Brenner; Derek A G Barisas; Kendal A Karpe; Martin L Moore; Helene F Rosenberg
Journal:  J Virol       Date:  2015-11-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.